{"organizations": [], "uuid": "3380ac48c9d75440202a82beea96918ed622ec6d", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-vbl-therapeutics-receives-mileston/brief-vbl-therapeutics-receives-milestone-payment-from-nanocarrier-under-licensing-agreement-for-vb-111-in-japan-idUSASB0C4QY", "country": "US", "domain_rank": 408, "title": "BRIEF-VBL Therapeutics Receives Milestone Payment From Nanocarrier Under Licensing Agreement For VB-111 In Japan", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.202, "site_type": "news", "published": "2018-02-08T20:16:00.000+02:00", "replies_count": 0, "uuid": "3380ac48c9d75440202a82beea96918ed622ec6d"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-vbl-therapeutics-receives-mileston/brief-vbl-therapeutics-receives-milestone-payment-from-nanocarrier-under-licensing-agreement-for-vb-111-in-japan-idUSASB0C4QY", "ord_in_thread": 0, "title": "BRIEF-VBL Therapeutics Receives Milestone Payment From Nanocarrier Under Licensing Agreement For VB-111 In Japan", "locations": [], "entities": {"persons": [{"name": "nanocar", "sentiment": "negative"}, {"name": "rier", "sentiment": "none"}], "locations": [{"name": "japan", "sentiment": "none"}, {"name": "japan", "sentiment": "none"}], "organizations": [{"name": "biogenics ltd", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 8 (Reuters) - Vascular Biogenics Ltd:\n* VBL THERAPEUTICS RECEIVES MILESTONE PAYMENT FROM NANOCARRIER UNDER LICENSING AGREEMENT FOR VB-111 IN JAPAN\n* VBL THERAPEUTICS RECEIVES MILESTONE PAYMENT FROM NANOCARRIER UNDER LICENSING AGREEMENT FOR VB-111 IN JAPAN\n* ‍AMOUNT OF RECENT MILESTONE PAYMENT WAS NOT DISCLOSED.​ Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-08T20:16:00.000+02:00", "crawled": "2018-02-08T14:28:29.000+02:00", "highlightTitle": ""}